Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels	Hypersensitivity, Immediate, food allergy, immune system disorder	Recruiting	Phase 2	2026-06-08		NCT06934200

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Genentech, Inc.	221
Johns Hopkins University	579

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Johns Hopkins	Baltimore	United States	39

Clinical trials